Related Experiment Video

Updated: May 24, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Telaprevir for the treatment of hepatitis C

Nicole Forestier1, Stefan Zeuzem

  • 1J. W. Goethe University Hospital, Department of Medicine, 1, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany.

Expert Opinion on Pharmacotherapy
|February 16, 2012
PubMed

Insights

Triple therapy with telaprevir, Peg-IFN-α, and ribavirin is the new standard for treating chronic hepatitis C genotype 1. Future treatments may include oral direct antiviral drug combinations.

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Chronic hepatitis C virus (HCV) infection affects over 180 million globally, leading to severe liver disease.
  • HCV genotype 1 treatment with Peg-IFN-α and ribavirin yields suboptimal sustained virologic response (SVR) rates of 40-50% and causes side effects.
  • Advancements in understanding HCV lifecycle and protein structures have led to the development of direct antiviral drugs (DAAs).

Purpose of the Study:

  • To review the clinical development of telaprevir.
  • To discuss the potential of telaprevir combined with Peg-IFN-α and ribavirin as a new standard HCV treatment.
  • To explore future challenges and treatment strategies for HCV infection.

Main Methods:

  • Literature review of telaprevir's clinical development.
  • Analysis of telaprevir's efficacy in combination therapy for HCV genotype 1.
  • Discussion of current and future HCV treatment paradigms.

Main Results:

  • Triple therapy with telaprevir, Peg-IFN-α, and ribavirin establishes a new standard of care for HCV genotype 1.
  • Next-generation DAAs are in development for combination therapy with Peg-IFN-α.
  • Oral DAA combinations represent a potential future treatment strategy.

Conclusions:

  • Telaprevir-based triple therapy is the current standard for HCV genotype 1.
  • Ongoing development of next-generation DAAs and oral combinations promises improved HCV treatment outcomes.
  • The evolution of HCV therapy is moving towards more effective and potentially all-oral regimens.
Abstract

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...